UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
February 23, 2006
Tapestry Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
| 0-24320 |
| 84-1187753 |
(State of incorporation) |
| (Commission File Number) |
| IRS Employer Identification No.) |
4840 Pearl East Circle, Suite 300W
Boulder, Colorado 80301
(Address of principal executive offices and zip code)
(303) 516-8500
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 2.02. Results of Operation and Financial Condition.
On February 23, 2006, Tapestry Pharmaceuticals, Inc. issued a press release announcing its earnings for the fourth quarter and year ended December 28, 2005. A copy of the press release is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit |
| Description |
99.1 |
| Press release dated February 23, 2006 issued by Tapestry Pharmaceuticals, Inc. |
The information in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 23, 2006
| TAPESTRY PHARMACEUTICALS, INC. | |
|
| |
|
| |
| By: | /s/ GORDON LINK |
|
| Gordon Link |
|
| Senior Vice President, |
|
| Chief Financial Officer |
3
Exhibit Index
Exhibit |
| Description |
99.1 |
| Press release dated February 23, 2006 issued by Tapestry Pharmaceuticals, Inc. |
4